Form 8-K - Current report:
SEC Accession No. 0000950170-25-012874
Filing Date
2025-02-04
Accepted
2025-02-04 09:05:40
Documents
12
Period of Report
2025-01-30
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tsbx-20250130.htm   iXBRL 8-K 52395
2 EX-99.1 tsbx-ex99_1.htm EX-99.1 15187
  Complete submission text file 0000950170-25-012874.txt   191448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20250130.xsd EX-101.SCH 26014
14 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20250130_htm.xml XML 4923
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 25585633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)